Overview / Abstract: |
STATEMENT OF NEED Soft tissue sarcomas are a heterogeneous group of malignancies that arise primarily from the mesodermal tissues of the extremities, trunk and retroperitoneum, and head and neck. An estimated 13,130 new cases are diagnosed in the United States annually and 5,350 people die of the disease. Surgical resection is the mainstay of treatment for localized soft tissue sarcoma, with radiation and chemotherapy commonly used as adjuncts. However, nearly 50% of patients will experience locoregional recurrence, distant metastases, or both. The outlook for those with unresectable and metastatic disease is poor, with median overall survival in the order of 1 year. TARGET AUDIENCE Medical oncologists, surgical oncologists, radiation oncologists, pathologists, oncology advanced practitioners, oncology nurses, and other health care professionals involved in the treatment of patients with soft tissue sarcoma. LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: 1.) Distinguish patient and tumor characteristics that can inform personalized therapeutic approaches in soft tissue sarcoma |
Expiration |
Oct 29, 2021 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
0.75 CME/NCPD, 0.4 hours of pharmacotherapy credit |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
FACULTY Vicki L. Keedy, MD, MSCI (Chairperson) Brian P. Rubin, MD, PhD Kathleen Polson, NP |
Activity Specialities / Related Topics |
Oncology / Cancer / Radiation Therapy, Pathology |
Sponsors / Supporters / Grant Providers |
This activity is supported by independent educational grants from Deciphera Pharmaceuticals, Inc., Epizyme, and Eisai. |
Keywords / Search Terms |
i3 Health oncology, CME, CNE, NCPD, CE, free CME, free NCPD, ILNA points, free ILNA points, MOC Free CE CME |